Sizable proportion of patients nonadherent to glaucoma meds

Sizable proportion of patients nonadherent to glaucoma meds

(HealthDay)—A considerable proportion of patients are nonadherent to glaucoma medication, but a telecommunication intervention can improve adherence, according to two studies published in the July issue of JAMA Ophthalmology.

Michael V. Boland, M.D., Ph.D., from the Wilmer Eye Institute at the John Hopkins University School of Medicine in Baltimore, and colleagues conducted a to examine adherence with once-daily glaucoma medication using an electronic monitor. Of the 407 patients who successfully completed a three-month adherence assessment, the researchers found that 82.8 percent were deemed adherent and took their medication correctly on at least 75 percent of days. The 70 nonadherent participants were slightly younger, were more likely to be of African descent, took medications for a shorter time, had a lower level of educational attainment, and had worse mental status and depression scale scores, compared with the adherent group.

In a second study, Boland and colleagues examined whether an automated telecommunication-based intervention could improve adherence. Seventy nonadherent participants were randomized to intervention (38 patients) and control groups. Patients in the received daily text or voice messages reminding them to take their medication. The researchers found that the median adherence rate increased from 53 to 64 percent in the group (P < 0.05). No statistical change was seen in the participants in the control group.

"Automated telecommunication-based reminders linked to data in a personal health record improved with once-daily glaucoma medications," Boland and colleagues write in the second study.

Both studies were supported by a grant from the Microsoft Be Well Fund.

More information: Abstract 1
Full Text (subscription or payment may be required)
Abstract 2
Full Text (subscription or payment may be required)

Related Stories

Info, motivation, behavioral skill affect med adherence

date Mar 12, 2014

(HealthDay)—Patients' adherence-related information, motivation, and behavioral skills (IMB) are important targets for interventions promoting adherence to diabetes medications, according to a study published ...

Recommended for you

Miniature pump regulates internal ocular pressure

date Jul 01, 2015

Elevated or diminished eye pressure impairs our ability to see, and in the worst cases, can even lead to blindness. Until now, there has been no effective long-term treatment. In response, Fraunhofer researchers are developing ...

Closing the Australian eye health gap may be in sight

date Jun 30, 2015

Three years after the launch of the roadmap to close the gap for vision, progress has been made but "much remains to be done", according to the authors of a Perspective published online today by the Medical Jo ...

Pioneering gene therapy takes aim at inherited blindness

date Jun 29, 2015

Canada's first human gene therapy trial for eyes—the replacement of a faulty gene with a healthy one—is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people ...

Iris research focuses on blood vessel patterns

date Jun 29, 2015

The structure of the microvasculature or blood vessels in the iris could play an important role in people's contraction of eye maladies like glaucoma and cataract, according to a WA-led study.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.